Clinical Trial: Efficacy of Immediate Allogeneic Hematopoietic Stem Cell Transplantation Versus Bridging Therapy Followed by Transplantation in Higher-Risk Myelodysplastic Syndrome Patients

U.S., April 10 -- ClinicalTrials.gov registry received information related to the study (NCT06918834) titled 'Efficacy of Immediate Allogeneic Hematopoietic Stem Cell Transplantation Versus Bridging Therapy Followed by Transplantation in Higher-Risk Myelodysplastic Syndrome Patients' on March 11.

Brief Summary: This study aims to evaluate whether immediate allogeneic hematopoietic stem cell transplantation (HSCT) is non-inferior to HSCT following bridging therapy in patients with higher-risk myelodysplastic syndrome (HR-MDS).

Study Start Date: April 01

Study Type: INTERVENTIONAL

Condition: Myelodysplastic Syndromes

Intervention: OTHER: Immediate HSCT Group

Patients undergo direct allogeneic HSCT.

OTHER: Bridging Therapy Group

Pati...